Published in Drug Law Weekly, October 9th, 2007
"Based on this analysis, we propose an update to the classification of the type II collagen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.